retium

CY 2023 Medicare Advantage and Prescription Drug Program Proposed Rule

CMS issued its proposed rule for Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs.

CMS is “proposing to require an applicant to demonstrate compliance with network adequacy standards as part of the MA application process for new and expanding service areas and to adopt a time-limited 10 percentage point credit toward meeting the applicable network adequacy standards for the application evaluation”. This will start with CY 2024.